HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer

HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer

Late recurrence of estrogen receptor (ER) positive breast cancer is common. When tissues from a recurrent or metastatic focus are available, re-evaluation of ER, progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2) status is recommended for treatment selection. This case...

Full description

Bibliographic Details
Main Authors: Miyuki Kitahara, Yasuo Hozumi, Ayaka Nakamura, Kana Tachi, Hitoaki Saitoh, Tatsuo Iijima
Format: Article
Language:English
Published: Karger Publishers 2019-06-01
Series:Case Reports in Oncology
Subjects:
Breast cancer
Late recurrence
Heterogeneity
HER2
Online Access:https://www.karger.com/Article/FullText/501306

Internet

https://www.karger.com/Article/FullText/501306

Similar Items